🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the safety and effectiveness of giving rivogenlecleucel...
Status
Terminated
Location
TriStar Bone Marrow Transplant, LLC
Start Date
2018-12-27
Trial ID
NCT03699475
Treatments Being Tested
This study will examine the safety and effectiveness of a bone marrow trans...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-10-01
Trial ID
NCT05900401
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
This study compares haplo-identical family donor stem cell transplantation ...
Status
Terminated
Location
Medical University of Vienna
Start Date
2019-11-12
Trial ID
NCT04067180
The purpose of this study is to test the hypothesis that a pre-infusion pre...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2004-01
Trial ID
NCT00167180
Treatments Being Tested
RATIONALE: Bone marrow transplantation may be able to replace immune cells ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2000-02
Trial ID
NCT00005988
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Severe congenital neutropenia (SCN) is a group of primary immunodeficiencie...
Status
Unknown
Location
HSCT department
Start Date
2021-04-14
Trial ID
NCT04844177
Treatments Being Tested
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested